As more than $50 billion makes its way to state and local governments to compensate for the opioid epidemic, people with high hopes for the money are already fighting over a little-known bureaucratic arm of the process: state councils that wield immense power over how the cash is spent.
Lexeo Therapeutics joins small class of 2023 biotech IPOs in $100M Nasdaq listing
Lexeo Therapeutics will begin trading on the Nasdaq on Friday morning via a $100 million initial public offering. The cardiac and Alzheimer’s gene therapy biotech
November 4, 2023